Hepion Pharmaceuticals ROCE 2024

Hepion Pharmaceuticals Aktienanalyse

What does Hepion Pharmaceuticals do?

Hepion Pharmaceuticals Inc. is a biopharmaceutical company focused on researching and developing therapeutics for the treatment of liver diseases. The company was founded in 2013 and is headquartered in Edison, New Jersey. The history of Hepion Pharmaceuticals Inc. began with the discovery of a new approach to treating liver diseases. Researchers found that small molecules targeting specific cells in the liver could have a positive effect on liver function. Hepion used this discovery as a starting point for developing new drugs to treat liver diseases. Hepion Pharmaceuticals Inc.'s business model is based on the development and marketing of innovative therapeutics for a variety of liver diseases, including fatty liver disease, alcoholic liver disease, non-alcoholic steatohepatitis (NASH), liver fibrosis, liver cirrhosis, and liver cancer. Hepion Pharmaceuticals has several divisions, all focused on the development of therapeutics for liver diseases. The primary division is research and development, which focuses on identifying and developing new drugs for the liver. Another important division is clinical development, where the drugs are tested and validated in clinical trials. The third division is marketing, where the therapeutics are marketed and sold. Hepion Pharmaceuticals Inc. currently offers two products. The first product is CRV431, a top-notch inhibitor of cytokine-mediated signaling. It is an orally administered drug specifically developed for the treatment of liver fibrosis. CRV431 aims to inhibit cytokine-mediated signaling responsible for fibrosis formation. The second product is an idiosyncratic database marketed under the name AI-Enabler. It is touted by the company as a groundbreaking tool for more precise medicine and research in support of drug development work. Overall, Hepion Pharmaceuticals Inc. is a promising biopharma company with a clear focus on developing new drugs for the treatment of liver diseases. With its innovative products and expertise in research and development, the company collaborates closely with partners from the scientific, industrial, and governmental sectors. It is hoped that this company will make further pioneering discoveries in the future and contribute to the benefit of human health. Hepion Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Hepion Pharmaceuticals's Return on Capital Employed (ROCE)

Hepion Pharmaceuticals's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Hepion Pharmaceuticals's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Hepion Pharmaceuticals's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Hepion Pharmaceuticals’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Hepion Pharmaceuticals Stock

What is the ROCE (Return on Capital Employed) of Hepion Pharmaceuticals this year?

The ROCE of Hepion Pharmaceuticals is -6.22 undefined this year.

How has the ROCE (Return on Capital Employed) of Hepion Pharmaceuticals developed compared to the previous year?

The ROCE of Hepion Pharmaceuticals has increased by 609.67% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Hepion Pharmaceuticals?

A high Return on Capital Employed (ROCE) indicates that Hepion Pharmaceuticals has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Hepion Pharmaceuticals?

A low ROCE (Return on Capital Employed) can indicate that Hepion Pharmaceuticals has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Hepion Pharmaceuticals impact the company?

An increase in the ROCE of Hepion Pharmaceuticals can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Hepion Pharmaceuticals affect the company?

A decrease in ROCE of Hepion Pharmaceuticals can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Hepion Pharmaceuticals?

Some factors that can affect Hepion Pharmaceuticals's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Hepion Pharmaceuticals so important for investors?

The ROCE of Hepion Pharmaceuticals is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Hepion Pharmaceuticals take to improve the ROCE?

To improve the ROCE, Hepion Pharmaceuticals can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Hepion Pharmaceuticals pay?

Over the past 12 months, Hepion Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Hepion Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Hepion Pharmaceuticals?

The current dividend yield of Hepion Pharmaceuticals is .

When does Hepion Pharmaceuticals pay dividends?

Hepion Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Hepion Pharmaceuticals?

Hepion Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Hepion Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Hepion Pharmaceuticals located?

Hepion Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Hepion Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Hepion Pharmaceuticals from 6/6/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/6/2024.

When did Hepion Pharmaceuticals pay the last dividend?

The last dividend was paid out on 6/6/2024.

What was the dividend of Hepion Pharmaceuticals in the year 2023?

In the year 2023, Hepion Pharmaceuticals distributed 0 USD as dividends.

In which currency does Hepion Pharmaceuticals pay out the dividend?

The dividends of Hepion Pharmaceuticals are distributed in USD.